The collaboration gives Covance access to Sleep Medicine Associates’ clinical research facility and specialized support for studies targeting insomnia, restless leg syndrome, narcolepsy, fibromyalgia, and other conditions related to the central nervous system.
Under the terms of the partnership, board certified sleep expert David Cocanower, M.D., will provide specialized sleep and neurological monitoring services to the CRO, as well as provide consultation on sleep-specific protocols and study design. Sleep Medicine’s eight-bed research facility is located near Covance’s Evansville, Ill., clinical research unit.
“We are excited to expand our sleep therapeutic expertise, capacity, and recruitment capabilities to better support client needs in this highly specialized area,” said Randall Stoltz, M.D., CPI, medical director, Covance, in a statement. “Sleep Medicine Associates adds industry-leading expertise and cutting edge technology to Covance’s portfolio of clinical development services.”